Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 4Carcinoma, Hepatocellular 2Small Cell Lung Carcinoma 1Motor Activity 1Lung Neoplasms 1Glioblastoma 1Fibrosis 1Epilepsy 1Cognitive Dysfunction 1Breast Neoplasms 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

mazdutide 1lithium sulfate 1lime 1fasudil 1blueberry extract 1Walking 1Transcranial Magnetic Stimulation 1Transcranial Direct Current Stimulation 1Therapeutics 1Tablets 1Radiotherapy 1Patient Reported Outcome Measures 1Organization and Administration 1Neuropsychological Tests 1Modafinil 1Methods 1Metformin 1Memantine 1Low-Level Light Therapy 1Lithium 1Infliximab 1Drug Therapy 1Data Collection 1Cognitive Behavioral Therapy 1Chemoradiotherapy 1Accidental Falls 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cognitive Dysfunction × Memantine × Clear all
NCT06727773 2026-05-06

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
90 enrolled
Breast

Breast Neoplasms, Motor Activity, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡